Intellia Therapeutics, Inc. - COM (NTLA)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM
Number of holders
291
Total Shares
78M
Shares change
+10M
Total reported value, excl. options
$2.72B
Value change
+$325M
Put/Call ratio
0.55
Number of buys
156
Number of sells
-132
Price
$34.89
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.